Simplify Asset Management Inc. Purchases 25,844 Shares of GE HealthCare Technologies Inc. $GEHC

Simplify Asset Management Inc. raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 91.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 54,028 shares of the company’s stock after acquiring an additional 25,844 shares during the period. Simplify Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $4,431,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $26,000. Optima Capital LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $27,000. Montag A & Associates Inc. raised its stake in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the period. Maseco LLP bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $29,000. Finally, Eagle Bay Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $33,000. 82.06% of the stock is currently owned by institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other news, insider Frank R. Jimenez acquired 1,750 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was purchased at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the acquisition, the insider owned 93,932 shares of the company’s stock, valued at $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Peter J. Arduini acquired 4,169 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was purchased at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. This represents a 1.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 11,847 shares of company stock valued at $719,555 over the last 90 days. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $64.23 on Monday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The business has a 50-day simple moving average of $68.45 and a 200 day simple moving average of $76.26. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The stock has a market cap of $29.22 billion, a price-to-earnings ratio of 15.37, a PEG ratio of 1.45 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the previous year, the firm earned $1.01 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on GEHC shares. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Piper Sandler decreased their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Barclays decreased their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 30th. Argus decreased their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday, May 19th. Finally, Oppenheimer reiterated an “outperform” rating and set a $85.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $80.21.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.